Clonazepam treatment of lysergic acid diethylamide-induced hallucinogen persisting perception disorder with anxiety features. March 1, 2003
Effects of the 5-HT2A Agonist Psilocybin on Mismatch Negativity Generation and AX-Continuous Performance Task: Implications for the Neuropharmacology of Cognitive Deficits in Schizophrenia February 1, 2003
Effects of different subanaesthetic doses of (S)-ketamine on psychopathology and binocular depth inversion in man January 1, 2003
Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers June 24, 2002
Flashback and Hallucinogen Persisting Perception Disorder: clinical aspects and pharmacological treatment approach. January 1, 2002
No Difference in Brain Activation During Cognitive Performance Between Ecstasy (3,4-Methylenedioxymethamphetamine) Users and Control Subjects: A [H215O]-Positron Emission Tomography Study February 1, 2001
LSD-induced hallucinogen persisting perception disorder treatment with clonidine: an open pilot study. January 1, 2000
